Camp4 Therapeutics revenue was $4.22M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $1.8M, up 37.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CAMP annual revenue was $3.5M, with 436.5% growth year-over-year.
CAMP past revenue growth
How has CAMP's revenue growth performed historically?
On Aug 13, 2026, Camp4 Therapeutics (NASDAQ: CAMP) reported Q2 2026 revenue of $1.78 million up 18.84% year over year. In the same quarter last year, Camp4 Therapeutics's revenue was $1.50 million.
What was Camp4 Therapeutics's revenue in 2025?
Camp4 Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $3.50 million, a 436.5% increase year over year.
How much does Camp4 Therapeutics make in a day?
Based on Camp4 Therapeutics annual revenue for the past three years, CAMP makes an average of $4,109.59 per day.
What was Camp4 Therapeutics's annual revenue growth in the past year?
As of Q3 2026, Camp4 Therapeutics's revenue has grown 40.21% year over year. This is 232.92 percentage points lower than the US Biotechnology industry revenue growth rate of 273.12%. Camp4 Therapeutics's revenue in the past year totaled $4.22 million.
How much does Camp4 Therapeutics make in a year?
Camp4 Therapeutics's revenue by year for the past three years is:
Camp4 Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $3.50 million, a 436.5% increase year over year.
Camp4 Therapeutics's annual revenue for Dec 31, 2024 was $652.00 thousand, a 86.29% increase from 2023.
Camp4 Therapeutics's annual revenue for 2023 was $350.00 thousand, a Infinity% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.